(10-160) Evaluation of a Pharmacist Directed Treat to Target Approach in Patients with Inflammatory Bowel Disease Receiving Upadacitinib or Risankizumab
Wednesday, December 6, 2023
11:00 AM – 12:00 PM
Location: Hall E, Lower Level
Co-Author(s): Archariya Puangampai, Bernice Man, Huda-Marie Kandah, David Choi